Table 1. Patients characteristics.
Variables | Subjects (n = 17) |
---|---|
Age (years), median, IQR* | 71, 66–80 |
Gender (Male / Female) | 14 / 3 |
Body mass index (kg/m2), median, IQR* | 22.0, 20.8–22.8 |
Comorbidities | |
Smoking history, number, percentage | 12, 70.6% |
Hypertension, number, percentage | 14, 82.4% |
Dyslipidemia, number, percentage | 12, 70.6% |
Coronary artery disease, number, percentage | 3, 17.6% |
Cerebrovascular disease, number, percentage | 5, 29.4% |
Diabetes mellitus, number, percentage | 12, 70.6% |
Medications | |
Ca-blocker, number, percentage | 10, 58.8% |
β-blocker, number, percentage | 3, 17.6% |
Hemodynamical parameters | |
Ankle brachial pressure index, median, IQR* | 0.82, 0.63–0.98 |
Reactive hyperemia index, median, IQR* | 1.46, 1.36–1.68 |
Laboratory findings | |
White blood cell (/μl), median, IQR* | 6400, 5700–7300 |
Hemoglobin (g/dl), median, IQR* | 12.8, 12.2–14.7 |
Platelet (x104/μl), median, IQR* | 21.6, 18.9–25.2 |
Prothrombin time (%), median, IQR* | 101.8, 91.7–107.3 |
Activated partial thromboplastin time (sec), median, IQR* | 28.4, 27–30.1 |
Fibrinogen (mg/dl), median, IQR* | 304, 269–317 |
D-Dimer (μg/ml), median, IQR* | 1.06, 0.78–2.10 |
Creatinine (mg/dl), median, IQR* | 0.92, 0.78–1.44 |
Total cholesterol (mg/dl), median, IQR* | 193, 160–205 |
Triglycerides (mg/dl), median, IQR* | 92, 71–205 |
High-density lipoprotein (mg/dl), median, IQR* | 54, 48–67 |
Low-density lipoprotein (mg/dl), median, IQR* | 116, 101–121 |
Hemoglobin A1c (%), median, IQR* | 6.75, 6.45–7.05 |
C-reactive protein (mg/dl), median, IQR* | 0.08, 0.05–0.17 |
Thrombomodulin (FU/ml) | 18.5, 13.7–21.3 |
* IQR, interquartile range.